The Quantellect read.As of Nov 19, 2026, 22 active firms cover Medtronic PLC: 15 rate it Buy or better, 7 sit at Neutral, and 0 rate it Sell or worse, a buy consensus. Targets span $83.00 to $118.00, a moderate spread. The average target of $103.62 sits 2% above the current $101.25. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees consensus EPS building from about $1.42 next quarter toward $6.41 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS22 active firms
Buy
Strong Buy00%
Buy1568%
Neutral732%
Sell00%
Strong Sell00%
Based on 22 active firms as of Nov 19, 2026 (365-day activity window).
12-MONTH PRICE TARGET
$103.62
+2.3% upside
Average target across 21 active firms as of Nov 19, 2026 vs $101.25 current
Highest Target$118.00
Average Target$103.62
Lowest Target$83.00
Detailed analyst forecasts for MDT
Showing 1–25 of 25 named analysts shown · 22 active firms in the rating projection
As of Nov 19, 2026, 15 of 22 active firms rate MDT a Buy (7 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
MDT EPS & revenue forecast
EPS · NEXT QUARTER
$1.42
Range $1.40 – $1.48 · 24 analysts · +5% YoY
Next period, 24 analysts expect Medtronic PLC to earn $1.42 a share (range $1.40 – $1.48), versus $1.36 a year earlier. Full-year consensus is $5.98, growing to $6.41 the year after.
REVENUE · NEXT QUARTER
$9.5B
Range $9.5B – $9.7B · 24 analysts · +6% YoY
Revenue is expected to reach $9.5B (range $9.5B – $9.7B), +5.6% year-over-year. Full-year consensus is $39.0B, rising to $40.4B next year.
Top analysts covering Medtronic PLC
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on MDT.
#1
Joanne Wuensch
Citigroup · Rank #35
Buy
$110.00+8.6% to target
Overall win rate
51%
+ Follow
#2
Anthony Petrone
Mizuho · Rank #121
Buy
$115.00+13.6% to target
Overall win rate
45%
+ Follow
#3
JB
Jayson Bedford
Raymond James · Rank #191
Neutral
No targeton MDT
Overall win rate
44%
+ Follow
#4
Ryan Zimmerman
BTIG · Rank #212
Buy
$99.00-2.2% to target
Overall win rate
37%
+ Follow
#5
Mike Matson
Needham · Rank #285
Buy
$114.00+12.6% to target
Overall win rate
36%
+ Follow
MDT stock forecast FAQ
What is MDT's average 12-month price target?+
The 21 active firms with a live target average $103.62 for Medtronic PLC over the next 12 months, ranging from a $118.00 high to a $83.00 low, as of Nov 19, 2026.
Is MDT stock a Buy, Sell or Neutral right now?+
The current consensus is Buy. Of the 22 active firms as of Nov 19, 2026, 15 rate it Buy or Strong Buy, 7 rate it Neutral, and 0 rate it Sell or Strong Sell.
What are the highest and lowest price targets for MDT?+
The Street-high target is $118.00 (RBC Capital), and the Street-low is $83.00 (Goldman Sachs). The average of all 21 active-firm targets is $103.62.
How many active Wall Street firms cover MDT?+
22 active firms have a recognized rating on Medtronic PLC as of Nov 19, 2026, and 21 active firms carry a live 12-month price target.
Who is the most accurate analyst covering MDT?+
Among analysts who currently cover MDT, Joanne Wuensch of Citigroup has the strongest overall Quantellect track record (Rank #35). Their current call is Buy with a $110.00 target.
What is Medtronic PLC's projected EPS for next quarter?+
The consensus estimate is $1.42 per share (range $1.40 – $1.48) across 24 analysts. Full-year EPS is projected at $5.98, rising to $6.41 the following year.
How much revenue is Medtronic PLC expected to report next quarter?+
Consensus revenue is $9.5B (range $9.5B – $9.7B). Full-year revenue is projected at $39.0B, growing to $40.4B next year.
Have analysts been upgrading or downgrading MDT lately?+
As of Nov 19, 2026, 15 of 22 active firms rate MDT a Buy (7 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their MDT calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.